CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 843,000	$ 477,010
Financial royalty assets	660,482	738,438
Available for sale debt securities	29,000	18,300
Other royalty income receivable	22,227	22,405
Other current assets	5,010	18,040
Total current assets	1,559,719	1,274,193
Financial royalty assets, net	13,465,407	14,088,655
Equity securities	277,217	199,487
Available for sale debt securities	473,700	437,100
Equity method investments	350,355	375,894
Other assets	4,488	6,522
Total assets	16,130,886	16,381,851
Current liabilities
Distributions payable to legacy non-controlling interests	91,409	83,155
Accounts payable and accrued expenses	11,551	15,165
Interest payable	12,595	51,682
Other current liabilities	9,019	11,375
Total current liabilities	124,574	161,377
Long-term debt	6,139,376	6,135,285
Other liabilities	3,220	900
Total liabilities	6,267,170	6,297,562
Commitments and contingencies
Shareholders’ equity
Deferred shares, $0.000001 par value; issued and outstanding: 2024–388,927 and 2023–384,640	0	0
Additional paid-in capital	4,074,849	4,011,435
Retained earnings	2,427,448	2,517,583
Non-controlling interests	3,363,965	3,557,792
Treasury interests	(2,654)	(2,629)
Total shareholders’ equity	9,863,716	10,084,289
Total liabilities and shareholders’ equity	16,130,886	16,381,851
Class A Ordinary Shares
Shareholders’ equity
Common stock	45	45
Class B Ordinary Shares
Shareholders’ equity
Common stock	0	0
Class R Redeemable Shares
Shareholders’ equity
Common stock	$ 63	$ 63